Other disclosed activity · NAUT
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 5 | Suzuki KentaroChief Marketing Officer |  NAUTNautilus Biotechnology, Inc.Grant or award | A | — 160.0K sh | Mar 4, 2026 traded Mar 2, 2026 |
Chief Marketing Officer · Nautilus Biotechnology, Inc. · Common Stock
Open-market purchase
$6K reported value · new position
Disclosed 2 business days after execution (deadline: 2)
First recorded trade by this actor in this security
No clustered activity in the dataset
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 5 | Suzuki KentaroChief Marketing Officer | NAUTNautilus Biotechnology, Inc. Grant or award | A | — 160.0K sh | Mar 4, 2026 traded Mar 2, 2026 |
Read directly from the primary public document; every field below is as reported by the filer.
Value = shares × reported price per share
= $5,960
Suzuki Kentaro filed this Form 4 reporting a open-market purchase of NAUT on Nov 6, 2025. It became public on Nov 10, 2025. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
No field has changed since this record was first ingested.
No material filings recorded for this issuer.